Granite Point Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-43,195
| Closed | -$78K | – | 107 |
|
|
2018
Q2 | $78K | Sell |
43,195
-98,594
| -70% | -$178K | 0.01% | 99 |
|
|
2018
Q1 | $334K | Sell |
141,789
-120,587
| -46% | -$284K | 0.03% | 79 |
|
|
2017
Q4 | $494K | Buy |
262,376
+211,455
| +415% | +$398K | 0.05% | 76 |
|
|
2017
Q3 | $127K | Hold |
50,921
| – | – | 0.03% | 91 |
|
|
2017
Q2 | $140K | Sell |
50,921
-27,080
| -35% | -$74.5K | 0.03% | 92 |
|
|
2017
Q1 | $235K | Sell |
78,001
-12,058
| -13% | -$36.3K | 0.07% | 72 |
|
|
2016
Q4 | $284K | Hold |
90,059
| – | – | 0.23% | 69 |
|
|
2016
Q3 | $307K | Hold |
90,059
| – | – | 0.12% | 70 |
|
|
2016
Q2 | $206K | Buy |
+90,059
| New | +$206K | 0.09% | 72 |
|
|
2015
Q4 | $346K | Hold |
104,687
| – | – | 0.05% | 70 |
|
|
2015
Q3 | $253K | Sell |
104,687
-4,817
| -4% | -$11.6K | 0.17% | 74 |
|
|
2015
Q2 | $321K | Sell |
109,504
-32,982
| -23% | -$96.7K | 0.09% | 82 |
|
|
2015
Q1 | $572K | Hold |
142,486
| – | – | 0.21% | 66 |
|
|
2014
Q4 | $429K | Buy |
+142,486
| New | +$429K | 0.2% | 65 |
|